Transcriptome dysregulation by anthrax lethal toxin plays a key role in induction of human endothelial cell cytotoxicity

Cellular Microbiology

Volumn 12, Issue 7, 2010, Pages 891-905

  Rolando, Monica ^a,b,c   Stefani, Caroline ^a,b,c   Flatau, Gilles ^a,b,c   Auberger, Patrick ^a,c,d   Mettouchi, Amel ^d,e   Mhlanga, Musa ^f   Rapp, Ulf ^a,g   Galmiche, Antoine ^g   Lemichez, Emmanuel ^a,b,c,h  

^a CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

^b Toxines Microbiennes dans la relation hôte pathogènes   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d Mort cellulaire différentiation et cancer   (France)

^e INSERM   (France)

^f Synthetic biology ERA   (South Africa)

^g UNIVERSITY OF WÜRZBURG   (Germany)

^h CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANTHRAX TOXIN; CALPONIN; CASPASE 3; CORTACTIN; EARLY GROWTH RESPONSE FACTOR 1; MESSENGER RNA; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTOME; X LINKED INHIBITOR OF APOPTOSIS;

ARTICLE; BACILLUS ANTHRACIS; CONTROLLED STUDY; CYTOTOXICITY; DNA MICROARRAY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; REGULATOR GENE; SIGNAL TRANSDUCTION;

ANTIGENS, BACTERIAL; APOPTOSIS; BACTERIAL TOXINS; CASPASE 3; CELL LINE; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MICROSCOPY, FLUORESCENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

BACILLUS ANTHRACIS;

EID: 77954454308     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2010.01438.x     Document Type: Article

References (46)

1. Abrami L, Leppla SH, van der Goot FG. Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis. J Cell Biol 2006, 172:309-320.
2. Bolcome RE, Sullivan SE, Zeller R, Barker AP, Collier RJ, Chan J. Anthrax lethal toxin induces cell death-independent permeability in zebrafish vasculature. Proc Natl Acad Sci USA 2008, 105:2439-2444.
3. Bonuccelli G, Sotgia F, Frank PG, Williams TM, de Almeida CJ, Tanowitz HB. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection. Am J Physiol Cell Physiol 2005, 288:C1402-C1410.
4. Boyer L, Doye A, Rolando M, Flatau G, Munro P, Gounon P. Induction of transient macroapertures in endothelial cells through RhoA inhibition by Staphylococcus aureus factors. J Cell Biol 2006, 173:809-819.
5. Bradburne C, Chung MC, Zong Q, Schlauch K, Liu D, Popova T. Transcriptional and apoptotic responses of THP-1 cells to challenge with toxigenic, and non-toxigenic Bacillus anthracis. BMC Immunol 2008, 9:67.
6. Bradley KA, Mogridge J, Mourez M, Collier RJ, Young JA. Identification of the cellular receptor for anthrax toxin. Nature 2001, 414:225-229.
7. Collier RJ, Young JA. Anthrax toxin. Annu Rev Cell Dev Biol 2003, 19:45-70.
8. Danninger C, Gimona M. Live dynamics of GFP-calponin: isoform-specific modulation of the actin cytoskeleton and autoregulation by C-terminal sequences. J Cell Sci 2000, 113(21):3725-3736. Pt
9. Doye A, Mettouchi A, Bossis G, Clement R, Buisson-Touati C, Flatau G. CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. Cell 2002, 111:553-564.
10. Doye A, Boyer L, Mettouchi A, Lemichez E. Ubiquitin-mediated proteasomal degradation of Rho proteins by the CNF1 toxin. Methods Enzymol 2006, 406:447-456.
11. Duesbery NS, Webb CP, Leppla SH, Gordon VM, Klimpel KR, Copeland TD. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 1998, 280:734-737.
12. During RL, Li W, Hao B, Koenig JM, Stephens DS, Quinn CP, Southwick FS. Anthrax lethal toxin paralyzes neutrophil actin-based motility. J Infect Dis 2005, 192:837-845.
13. During RL, Gibson BG, Li W, Bishai EA, Sidhu GS, Landry J, Southwick FS. Anthrax lethal toxin paralyzes actin-based motility by blocking Hsp27 phosphorylation. EMBO J 2007, 26:2240-2250.
14. Fu M, Zhu X, Zhang J, Liang J, Lin Y, Zhao L. Egr-1 target genes in human endothelial cells identified by microarray analysis. Gene 2003, 315:33-41.
15. Gozes Y, Moayeri M, Wiggins JF, Leppla SH. Anthrax lethal toxin induces ketotifen-sensitive intradermal vascular leakage in certain inbred mice. Infect Immun 2006, 74:1266-1272.
16. Guicciardi ME, Gores GJ. Life and death by death receptors. FASEB J 2009, 23:1625-1637.
17. Huang C, Jacobson K, Schaller MD. MAP kinases and cell migration. J Cell Sci 2004, 117:4619-4628.
18. Indraccolo S, Pfeffer U, Minuzzo S, Esposito G, Roni V, Mandruzzato S. Identification of genes selectively regulated by IFNs in endothelial cells. J Immunol 2007, 178:1122-1135.
19. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, Narumiya S. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 2000, 57:976-983.
20. Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005, 21:247-269.
21. Khachigian LM. Early growth response-1 in cardiovascular pathobiology. Circ Res 2006, 98:186-191.
22. Kirby JE. Anthrax lethal toxin induces human endothelial cell apoptosis. Infect Immun 2004, 72:430-439.
23. Le Clainche C, Carlier MF. Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol Rev 2008, 88:489-513.
24. Lehmann M, Noack D, Wood M, Perego M, Knaus UG. Lung epithelial injury by B. anthracis lethal toxin is caused by MKK-dependent loss of cytoskeletal integrity. PLoS ONE 2009, 4:e4755.
25. Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, Conte D. Identification of XAF1 as an antagonist of XIAP anti-caspase activity. Nat Cell Biol 2001, 3:128-133.
26. Long X, Creemers EE, Wang DZ, Olson EN, Miano JM. Myocardin is a bifunctional switch for smooth versus skeletal muscle differentiation. Proc Natl Acad Sci USA 2007, 104:16570-16575.
27. Miano JM, Long X, Fujiwara K. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am J Physiol Cell Physiol 2007, 292:C70-C81.
28. Moayeri M, Leppla SH. The roles of anthrax toxin in pathogenesis. Curr Opin Microbiol 2004, 7:19-24.
29. Munro P, Flatau G, Doye A, Boyer L, Oregioni O, Mege JL. Activation and proteasomal degradation of rho GTPases by cytotoxic necrotizing factor-1 elicit a controlled inflammatory response. J Biol Chem 2004, 279:35849-35857.
30. Peck JW, Oberst M, Bouker KB, Bowden E, Burbelo PD. The RhoA-binding protein, rhophilin-2, regulates actin cytoskeleton organization. J Biol Chem 2002, 277:43924-43932.
31. Pezard C, Berche P, Mock M. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect Immun 1991, 59:3472-3477.
32. Posern G, Treisman R. Actin' together: serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol 2006, 16:588-596.
33. Raymond B, Batsche E, Boutillon F, Wu YZ, Leduc D, Balloy V. Anthrax lethal toxin impairs IL-8 expression in epithelial cells through inhibition of histone H3 modification. PLoS Pathog 2009, 5:e1000359.
34. Rigaud S, Fondaneche MC, Lambert N, Pasquier B, Mateo V, Soulas P. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006, 444:110-114.
35. Rmali KA, Al-Rawi MA, Parr C, Puntis MC, Jiang WG. Upregulation of tumour endothelial marker-8 by interleukin-1beta and its impact in IL-1beta induced angiogenesis. Int J Mol Med 2004, 14:75-80.
36. Rolando M, Munro P, Stefani C, Auberger P, Flatau G, Lemichez E. Injection of Staphylococcus aureus EDIN by the Bacillus anthracis protective antigen machinery induces vascular permeability. Infect Immun 2009, 77:3596-3601.
37. Scobie HM, Rainey GJ, Bradley KA, Young JA. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci USA 2003, 100:5170-5174.
38. Selbach M, Backert S. Cortactin: an Achilles' heel of the actin cytoskeleton targeted by pathogens. Trends Microbiol 2005, 13:181-189.
39. Stearns-Kurosawa DJ, Lupu F, Taylor FB, Kinasewitz G, Kurosawa S. Sepsis and pathophysiology of anthrax in a nonhuman primate model. Am J Pathol 2006, 169:433-444.
40. van Sorge NM, Ebrahimi CM, McGillivray SM, Quach D, Sabet M, Guiney DG, Doran KS. Anthrax toxins inhibit neutrophil signaling pathways in brain endothelium and contribute to the pathogenesis of meningitis. PLoS ONE 2008, 3:e2964.
41. Sun J, Lang AE, Aktories K, Collier RJ. Phenylalanine-427 of anthrax protective antigen functions in both pore formation and protein translocation. Proc Natl Acad Sci USA 2008a, 105:4346-4351.
42. Wang Z, Wang DZ, Hockemeyer D, McAnally J, Nordheim A, Olson EN. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 2004, 428:185-189.
43. Warfel JM, Steele AD, D'Agnillo F. Anthrax lethal toxin induces endothelial barrier dysfunction. Am J Pathol 2005, 166:1871-1881.
44. Watanabe N, Kato T, Fujita A, Ishizaki T, Narumiya S. Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nat Cell Biol 1999, 1:136-143.
45. Wilde C, Vogelsgesang M, Aktories K. Rho-specific Bacillus cereus ADP-ribosyltransferase C3cer cloning and characterization. Biochem 2003, 42:9694-9702.
46. Wojciak-Stothard B, Ridley AJ. Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol 2003, 39:187-199.